Ferroportin (FP) mRNA expression was enhanced by FKN treatment, suggesting that, in shorter iron deficiency, FKN activates the liberation of iron from heme by HO-1, whose level was elevated by FKN, for maintaining the continuous iron export. The gene discussed is HMOX1; the disease is nutritional disorder.